ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2
Go back to ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2| (NASDAQ: PRQR) | Delayed: 1.81 +0.06 (3.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.75 | 52 Week High | $13.33 | |||
| Open | $1.74 | 52 Week Low | $3.48 | |||
| Day High | $1.85 | P/E | N/A | |||
| Day Low | $1.69 | EPS | $0.00 | |||
| Volume | 1,189,309 | |||||
